Infective Endocarditis (IE) Mortality Risk Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
mortality probability
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–10
  • Moderate Risk10–25
  • High Risk25–50
  • Very High Risk50–100
Direct Clinical Answer

The Infective Endocarditis (IE) Mortality Risk Score calculates predicting 6-month mortality in patients with infective endocarditis using validated clinical parameters. Key inputs include age category. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts 6-month mortality in patients with infective endocarditis using validated clinical parameters. This risk stratification tool was developed from the International Collaboration on Endocarditis (ICE) Prospective Cohort Study and helps clinicians assess prognosis and guide treatment decisions in patients with definite infective endocarditis. The score incorporates host factors, IE characteristics, and complications to provide mortality risk prediction.

Clinical Indication

The Infective Endocarditis (IE) Mortality Risk Score is indicated for bedside clinical practice to support Predicts 6-month mortality in patients with infective endocarditis using validated clinical parameters. This risk stratification tool was developed from the International Collaboration on Endocarditis (ICE) Prospective Cohort Study and helps clinicians assess prognosis and guide treatment decisions in patients with definite infective endocarditis. The score incorporates host factors, IE characteristics, and complications to provide mortality risk prediction.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Score ≥8 has sensitivity 86.7%, specificity 50.8%, NPV 86% for 6-month mortality.

Formula & Variables:

Score = sum of all parameter points; Probability of 6-month mortality (%) = 100 × [1 / (1 + exp(-(2.416×score + 0.109×score² - 4.849)))]

Input Parameters

NameTypeRequiredDescription
age_categorystringYesPatient age category. Older age associated with increased mortality risk
history_of_dialysisstringYesHistory of chronic dialysis treatment. Dialysis patients have higher mortality risk
nosocomial_iestringYesHealthcare-associated infective endocarditis. Associated with worse outcomes
prosthetic_iestringYesProsthetic valve infective endocarditis. Associated with higher mortality
symptoms_over_1_monthstringYesSymptoms present for more than 1 month before admission. Longer symptom duration may indicate lower acuity
staphylococcus_aureusstringYesStaphylococcus aureus as causative pathogen. Associated with more aggressive disease
viridans_group_streptococcistringYesViridans group streptococci as causative pathogen. Generally associated with better prognosis
aortic_vegetationstringYesPresence of aortic valve vegetation on echocardiography
mitral_vegetationstringYesPresence of mitral valve vegetation on echocardiography
nyha_class_3_or_4_hfstringYesNYHA Class 3 or 4 heart failure. Severe heart failure associated with poor prognosis
strokestringYesStroke complication during IE episode. Major embolic complication
paravalvular_complicationstringYesParavalvular complications (abscess, fistula, pseudoaneurysm). Indicates severe local tissue destruction
persistent_bacteremiastringYesPersistent bacteremia despite appropriate antibiotic treatment. Indicates treatment failure
surgical_treatmentstringYesSurgical treatment performed during index hospitalization. Associated with improved survival when appropriately selected

Score Interpretation & Guidance

RangeStageDescription
0–10Low RiskMortality probability ≤10%
10–25Moderate RiskMortality probability 10-25%
25–50High RiskMortality probability 25-50%
50–100Very High RiskMortality probability >50%

Evidence-Based References (EBM)

  • Gunes M, Gecmen C, Beker Evans M, et al. Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis. J Am Heart Assoc. 2017 Apr 7;6(4):e003016. doi: 10.1161/JAHA.115.003016.DOI: 10.1161/JAHA.115.003016
  • Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9;169(5):463-73. doi: 10.1001/archinternmed.2008.603.DOI: 10.1001/archinternmed.2008.603
  • Cahill TJ, Baddour LM, Habib G, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017 Jul 25;70(3):325-335. doi: 10.1016/j.jacc.2017.06.007.DOI: 10.1016/j.jacc.2017.06.007

Related calculators